Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-964"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101124.15.3-964"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted in favour of the proposal for a directive as regards information to the general public on medicinal products for human use subject to medical prescription because I believe that harmonising the laws in this sector is a fundamental means of safeguarding the knowledge of European patients. This is actually a very sensitive issue because it relates to health protection, which is a fundamental human right. I fully support this House’s call for a clear distinction to be made between therapeutic information and advertising. Pharmaceutical companies, in fact, must not use patients’ right to information as a vehicle for disguising their promotional aims but instead must use it to guarantee European consumers a real understanding of products, through the scientific indication of their characteristics, labelling and assessment reports. It should also be noted that greater access to information both in electronic form, available over the Internet, and in printed form can also contribute to the achievement of better medical results, because a patient who is informed about prescribed medicines is one who can play an active and more knowledgeable role in the therapeutic recovery process."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples